Atlas Trials

Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE

Clinical trial NCT03722498 · WITHDRAWN

Trial details

NCT number
NCT03722498
Sponsor
Sun Yat-sen University
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2018-06-01
Primary completion
2021-03-22
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.